Nuclear physicists have found a new way to see details inside atomic nuclei. The...
CHICAGO—March 24, 2023—Illinois Institute of Technology Assistant Professor Ren ...
Seagen generated almost $2bn in revenue in 2022, an increase approaching 25% fro...
In 2022, the biotech IPO market saw fewer offerings, and those that did manage t...
Biohaven is expecting to advance Hangzhou Highlightll’s BHV-8000 into a Phase I ...
While lifestyle modifications play a key role in treating PCOS, the paucity of n...
Incyte’s Zynyz is approved based on the data obtained from the POD1UM-201 trial.
Mass spectrometry is one of the most versatile technologies you can integrate in...
The MHRA introduces new changes to UK clinical trial regulation in hopes of reco...
A clear issue currently facing gastroenterologists treating CD is the lack of in...
CSPC Pharmaceutical’s SYS6006 has been designed to target some major Omicron var...
Healthcare providers are under pressure to address the growing issue of substanc...
Mutations in genes that form the desmosome are the most common cause of the card...
In nearly a month, the number of confirmed and probable cases has grown from nin...
The FDA panel voted 9-0 for conditional approval of Biogen's drug for a rare for...
The Biden administration said Wednesday it will attempt to break up the network ...
